Akihiro Yamanaka Selected Research

Akihiro Yamanaka Research Topics

Disease

17	Narcolepsy 02/2022 - 04/2005
10	Cataplexy 02/2022 - 05/2014
7	Pain (Aches) 12/2019 - 01/2011
6	Sleep Wake Disorders 02/2022 - 01/2012
4	Hyperalgesia 01/2022 - 03/2015
4	Infections 01/2020 - 01/2018
3	Nerve Degeneration 02/2022 - 02/2016
3	Mental Disorders (Mental Disorder) 01/2021 - 01/2019
3	Substance-Related Disorders (Drug Abuse) 01/2020 - 07/2006
2	Opioid-Related Disorders (Opiate Addiction) 12/2022 - 01/2018
2	Neoplasms (Cancer) 01/2022 - 01/2018
2	Hypothermia 01/2020 - 01/2018
1	Chronic Pain 01/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Cardiotoxicity 01/2021
1	Paralysis (Palsy) 01/2021
1	Hyperthermia 01/2020
1	Disorders of Excessive Somnolence (Hypersomnia) 11/2019
1	Hypersensitivity (Allergy) 11/2019
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Hypercapnia 11/2016
1	Sudden Infant Death (SID) 11/2016
1	Hypoxia (Hypoxemia) 11/2016
1	Obstructive Sleep Apnea 11/2016
1	Nervous System Diseases (Neurological Disorders) 11/2015
1	Gambling (Pathological Gambling) 07/2015
1	Fibromyalgia (Fibrositis) 03/2015
1	Body Weight (Weight, Body) 05/2014
1	Acidosis 01/2014
1	Ischemia 01/2014
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 06/2010
1	Sleep Deprivation 07/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2006
1	AIDS-Related Complex (ARC) 03/2004
1	Hyperphagia (Overeating) 05/2003

Drug/Important Bio-Agent (IBA)

26	OrexinsIBA 12/2022 - 03/2004
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2017
4	NeuropeptidesIBA 11/2021 - 04/2005
3	Doxycycline (Periostat)FDA LinkGeneric 02/2022 - 05/2014
3	Diphtheria ToxinIBA 02/2016 - 05/2014
2	Morphine (MS Contin)FDA LinkGeneric 12/2022 - 01/2018
2	Cre recombinaseIBA 01/2020 - 01/2018
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 01/2018
2	Acid Sensing Ion ChannelsIBA 11/2019 - 03/2015
2	CalciumIBA 01/2018 - 07/2006
2	4-nitrophenethyl bromide (NPB)IBA 01/2011 - 05/2003
1	Heroin (Diamorphine)IBA 12/2022
1	QuinpiroleIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Cocaine (Cocaine HCl)IBA 01/2020
1	Serotonin AgentsIBA 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2019
1	Tetracycline (Achromycin)FDA LinkGeneric 12/2019
1	amsonic acid (DAS)IBA 12/2019
1	Serotonin (5 Hydroxytryptamine)IBA 12/2019
1	Trans-Activators (Trans-Acting Factor)IBA 12/2019
1	Tryptophan (L-Tryptophan)FDA Link 12/2019
1	IsotopesIBA 10/2019
1	3-methoxytyramine (methoxytyramine)IBA 10/2019
1	preproenkephalinIBA 01/2019
1	G-CaMP6IBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	isospaglumic acid (NAAGA)IBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Designer DrugsIBA 01/2018
1	Opiate AlkaloidsIBA 01/2018
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 01/2017
1	Methamphetamine (Desoxyn)FDA LinkGeneric 07/2015
1	Minocycline (Cyclops)FDA LinkGeneric 03/2015
1	Reserpine (Serpasil)FDA Link 03/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	Ion Channels (Ion Channel)IBA 03/2015
1	Ataxin-3IBA 05/2014
1	Peptides (Polypeptides)IBA 05/2014
1	Baclofen FDA LinkGeneric 05/2014
1	Glutamic Acid (Glutamate)FDA Link 01/2014
1	AcidsIBA 06/2010
1	GABA-B ReceptorsIBA 07/2006
1	GABA-B Receptor AgonistsIBA 07/2006
1	Neuropeptide YIBA 03/2004
1	Glucose (Dextrose)FDA LinkGeneric 03/2004
1	LeptinIBA 03/2004
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 03/2004

Therapy/Procedure

4	Therapeutics 11/2021 - 05/2014
2	Ligation 01/2022 - 01/2018
1	Transplantation 01/2022
1	Induced Hypothermia 01/2020
1	Analgesia 01/2016
1	Subcutaneous Injections 03/2015
1	Intraperitoneal Injections 03/2015